XML 37 R26.htm IDEA: XBRL DOCUMENT v3.19.2
Stock-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2019
Share-based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense
Stock-based compensation expense for options granted, RSAs, performance stock awards (“PSAs”), SARs and stock purchase rights is reflected in the condensed consolidated statements of operations and comprehensive loss as follows: 
 
THREE MONTHS ENDED 
 JUNE 30,
 
SIX MONTHS ENDED 
 JUNE 30,
(in thousands)
2019
 
2018
 
2019
 
2018
Selling, general and administrative
$
7,091

 
$
7,126

 
$
16,212

 
$
13,340

Pre-approval commercial manufacturing
834

 
634

 
1,683

 
1,104

Research and development
2,770

 
2,558

 
5,420

 
4,593

Total
$
10,695

 
$
10,318

 
$
23,315

 
$
19,037


Schedule of Stock Options Activity
The following table summarizes the stock option activity under the Plans: 
 
NUMBER OF
SHARES
 
WEIGHTED AVERAGE
EXERCISE PRICE
 
WEIGHTED
AVERAGE
REMAINING
CONTRACTUAL
LIFE (YEARS)
 
AGGREGATE
INTRINSIC
VALUE
(000’s)
Options outstanding at December 31, 2018
6,935,119

 
$
28.97

 

 


Granted
914,790

 
43.32

 
 
 
 
Exercised
(124,034
)
 
30.94

 
 
 
 
Canceled
(211,607
)
 
53.52

 
 
 
 
Options outstanding at June 30, 2019
7,514,268

 
$
29.99

 
6.6
 
$
63,671

Options exercisable at June 30, 2019
5,145,383

 
$
21.98

 
5.6
 
$
61,881


Restricted Stock and Restricted Stock Units Activity
The following table summarizes the RSAs, including PSAs, activity under the Plans: 
 
NUMBER OF
SHARES
 
WEIGHTED AVERAGE
FAIR VALUE PER SHARE
Non-vested RSAs at December 31, 2018
572,706

 
$
48.18

Granted
392,784

 
45.55

Vested
(203,077
)
 
45.12

Canceled
(33,708
)
 
50.55

Non-vested RSAs at June 30, 2019
728,705

 
$
47.53


Schedule of Stock Appreciation Rights
The following table summarizes the SARs activity under the Plans:
 
NUMBER OF
SHARES
 
WEIGHTED AVERAGE
EXERCISE PRICE
 
WEIGHTED
AVERAGE
REMAINING
CONTRACTUAL
LIFE (YEARS)
 
AGGREGATE
INTRINSIC
VALUE
(000’s)
SARs outstanding at December 31, 2018
91,000

 
$
53.75

 
 
 
 
Granted
57,851

 
43.40

 
 
 
 
Exercised

 

 
 
 
 
Canceled
(19,445
)
 
50.87

 
 
 
 
SARs outstanding at June 30, 2019
129,406

 
$
49.55

 
4.1
 
$

SARs exercisable at June 30, 2019
18,000

 
$
54.19

 
3.7
 
$